Screener
Arbutus Biopharma Corporation ABUS Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
The source filing: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 7:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001447028-26-000021
FAQ
- What is Arbutus Biopharma Corporation's invested capital?
- Arbutus Biopharma Corporation (ABUS) reported invested capital of $237.1M in Q1 2026.
- How has Arbutus Biopharma Corporation's invested capital changed year-over-year?
- Arbutus Biopharma Corporation's invested capital increased by 448.0% year-over-year, from $43.27M to $237.1M.
- What is the long-term trend for Arbutus Biopharma Corporation's invested capital?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's invested capital has grown at a 2.4% compound annual growth rate (CAGR), from $52.7M to $59.31M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Arbutus Biopharma Corporation's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude